Celgene Ltd

Morgan House, Madeira Walk, Windsor, Berkshire, SL4 1PE, UK
Telephone: +44 1753 498 600
Medical Information Direct Line: UK: 08448 010 045 Ireland: 1800 333 111
Medical Information e-mail: medinfo.uk.ire@celgene.com
Medical Information Fax: UK: 08448 010 046 Ireland: 1800 333 112
Patient Information Leaflet last updated on the eMC: 09/02/2010
PIL Revlimid

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 09/02/2010 and displayed until Current
Reasons for adding or updating:
  • Change to information for healthcare professionals
  • Change to warnings or special precautions for use
Updated on 02/09/2009 and displayed until 09/02/2010
Reasons for adding or updating:
  • Change to side-effects
Updated on 01/05/2009 and displayed until 02/09/2009
Reasons for adding or updating:
  • Improved Electronic Presentation
  • Change to information about pregnancy or lactation
Updated on 03/07/2007 and displayed until 01/05/2009
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
   lenalidomide


© 2010 Datapharm Communications Ltd

Go to www.medicines.org.uk